Optipharm.CO.,LTD (KOSDAQ:153710)

Optipharm.CO.,LTD Revenue

Optipharm.CO.,LTD had revenue of 5.79B KRW in the quarter ending June 30, 2025, with 16.86% growth. This brings the company's revenue in the last twelve months to 21.09B, up 13.63% year-over-year. In the year 2024, Optipharm.CO.,LTD had annual revenue of 19.64B with 13.03% growth.

• Revenue (ttm): 21.09B
• Revenue Growth: +13.63%
• P/S Ratio: 3.50
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 73.79B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	19.64B	2.26B	13.03%
Dec 31, 2023	17.37B	1.36B	8.52%
Dec 31, 2022	16.01B	1.75B	12.27%
Dec 31, 2021	14.26B	1.21B	9.29%
Dec 31, 2020	13.05B	-606.93M	-4.45%